Diagnosis and Monitoring Segment to Dominate Asia Pacific Electrophysiology Catheter Market during 2019–2028

According to a new market research study on “Asia Pacific Electrophysiology Catheter Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product Type, Application, and End User,” is expected to reach US$ 1,677.80 million by 2028 from US$ 918.81 million in 2021. The market is estimated to grow at a CAGR of 9.0% from 2021 to 2028. Robotics in electrophysiology catheterization procedures is the major factor driving the growth of the Asia Pacific electrophysiology catheter market. However, high cost of electrophysiology catheters may hinder the growth of Asia Pacific electrophysiology catheter market. The report provides trends prevailing in the Asia Pacific electrophysiology catheter market along with the drivers and restraints pertaining to the market growth.

As per the Worldometer data as of March 2021, China, Japan, India, South Korea, and Australia have reported 90,066; 448,688; 11,438,734; 96,849; and 29,151 COVID-19 cases, respectively. The shrinking economies of many countries are limiting the progress of sectors such as pharmaceuticals. The extended pandemic period, combined with concerns about economic recovery, further harm the pharmaceutical business in Asia Pacific. A few research institutes in this region are actively participating in research targeted at the management of COVID-19. The major traction toward the management of COVID-19 has hampered the detection and treatment of noncommunicable diseases. It led to a significant and abrupt reduction in cardiovascular diagnostic testing across APAC.

The Asia Pacific electrophysiology catheter market is segmented into product type, application, end user, and country. The Asia Pacific electrophysiology catheter market, based on product type, has been classified electrophysiology diagnostic catheters and electrophysiology ablation catheters. In 2021, the electrophysiology diagnostic catheters segment held the largest share Asia Pacific electrophysiology catheter market. The electrophysiology diagnostic catheters are sub-segmented as conventional electrophysiology diagnostic catheters, advanced electrophysiology diagnostic catheters, and ultrasound electrophysiology diagnostic catheters. In 2021, the conventional electrophysiology diagnostic catheters segment held the largest share Asia Pacific electrophysiology catheter market. Further, electrophysiology ablation catheters are sub-segmented as cryoablation electrophysiology catheter, radiofrequency ablation catheters, microwave ablation systems, and laser ablation systems. In 2021, the cryoablation electrophysiology catheter segment held the largest share Asia Pacific electrophysiology catheter market. The Asia Pacific electrophysiology catheter market, based on application is segmented into diagnosis and monitoring, imaging and mapping, and treatment of cardiac arrhythmias. In 2021, the diagnosis and monitoring segment held the largest share Asia Pacific electrophysiology catheter market. The Asia Pacific electrophysiology catheter market, based on end user is segmented into hospitals, ambulatory surgical centers, and cardiac catheterization labs. In 2021, the hospitals segment held the largest share Asia Pacific electrophysiology catheter market. Based on country the Asia Pacific electrophysiology catheter market is segmented into the China, Japan, India, South Korea, Australia, and rest of Asia Pacific. In 2021, China held the largest share Asia Pacific electrophysiology catheter market.

Abbott; APT Medical Inc.; Biosense Webster (Johnson and Johnson Services, Inc.); Biotronik, Inc.; Boston Scientific Corporation; CathRx Ltd; Medtronic; MicroPort Scientific Corporation; Stryker Corporation; and Transonic Systems Inc. are among the leading companies in the Asia Pacific Electrophysiology Catheter Market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, MicroPort and Stereotaxis entered into a collaboration to advance technology innovation and commercial adoption of robotics in electrophysiology in China. The agreement bought MicroPort EP’s commercial and product leadership in China’s electrophysiology market with Stereotaxis’ advanced Robotic Magnetic Navigation technology. As part of the collaboration, MicroPort EP became the exclusive distributor of Robotic Magnetic Navigation technology for electrophysiology in China

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com